Fingerprint
Dive into the research topics of 'Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromes
Amer M. Zeidan, Franklin Hendrick, Erika Friedmann, Maria R. Baer, Steven D. Gore, Medha Sasane, Carole Paley, Amy J. Davidoff
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations